fda tirzepatide news restricts non-approved compounded GLP-1 weight loss products FDA confirms tirzepatide shortage is

Webster AN, Becker JJ, Li C, Schwalbe DC, Kerspern D, Karolczak EO, Bundon CB, Sun H, Hao Y, Liu H, Gao F (2025) The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment

The peptide signals tissue remodeling, collagen and elastin synthesis, and gene expression linked to wound repair

1 thing we can do to make sure that low-income, rural communities of color dont get left behind is to make sure that Medicaid is covering GLP-1s, and make sure that they have the information about that coverage so they know they have access to this life-changing medication. Burgin argues that addressing food choices and educational initiatives could also play a role

However, the research is mixed

For twice-daily administration, administer in the AM and at bedtime

Dosing chart for the 60 mg vial Once your vial is reconstituted, you need to know exactly how much liquid to draw for each dose